Partnerships Between Philanthropy, Government and Investors are Needed to Advance Drug Discovery for Neurodegenerative Diseases

Publisher： Bentham Science Publishers

E-ISSN： 1875-5828|3|3|175-176

ISSN： 1567-2050

Source： Current Alzheimer Research, Vol.3, Iss.3, 2006-07, pp. : 175-176

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Transglutaminase activation in neurodegenerative diseases

By Jeitner Thomas M   Muma Nancy A   Battaile Kevin P   Cooper Arthur JL  

Future Neurology, Vol. 4, Iss. 4, 2009-07 ,pp. : 449-467

Future Medicine

Access to resources Recommend Favorite

Polyphenols and neurodegenerative diseases

By Barreto George E.   Guedes Rubem C. A.  

Nutritional Neuroscience, Vol. 15, Iss. 3, 2012-05 ,pp. : 92-93

Maney Publishing

Access to resources Recommend Favorite

Molecular Mechanisms of Neurodegenerative Diseases, by

By Khachaturian Z.S.  

Journal of Alzheimer's Disease, Vol. 3, Iss. 6, 2001-01 ,pp. : 601-602

Ios Press

Access to resources Recommend Favorite

Molecular Mechanisms of Neurodegenerative Diseases.

By Chinnery P.F.  

Brain, Vol. 124, Iss. 7, 2001-07 ,pp. : 1467-1468

Oxford University Press

Access to resources Recommend Favorite

Commonalities in Biological Pathways, Genetics, and Cellular Mechanism between Alzheimer Disease and Other Neurodegenerative Diseases: An In Silico-Updated Overview

By  

Current Alzheimer Research, Vol. 14, Iss. 11, 2017-10 ,pp. : 1190-1197

Bentham Science Publishers

Access to resources Recommend Favorite